Five Prime Therapeutics, Inc. Capital Units, Authorized
Five Prime Therapeutics, Inc. had Capital Units, Authorized of 110.00 million shares as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Notes › Equity
us-gaap:CapitalUnitsAuthorized · last filed 2021-03-22
- 2020-12-31: Capital Units, Authorized 110.00M shares.
- 2019-12-31: Capital Units, Authorized 110.00M shares.
- 2018-12-31: Capital Units, Authorized 110.00M shares.
- 2017-12-31: Capital Units, Authorized 110.00M shares.
| Period end | Capital Units, Authorized |
|---|---|
| 2020-12-31 | 110.00M shares 10-K · filed 2021-03-22 |
| 2019-12-31 | 110.00M shares 10-K · filed 2020-02-27 |
| 2018-12-31 | 110.00M shares 10-K · filed 2019-02-26 |
| 2017-12-31 | 110.00M shares 10-K · filed 2018-02-27 |